Southeast Asset Advisors Inc. Repligen Corp Transaction History

Southeast Asset Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $765,439 - $1.02 Million	-5,441 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $12,250 - $19,604	76 Added 1.42%	5,441 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $20,797 - $25,575	84 Added 1.59%	5,365 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $13,244 - $22,046	68 Added 1.3%	5,281 $1.53 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $13,269 - $17,676	80 Added 1.56%	5,213 $1.04 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $901 - $1,131	5 Added 0.1%	5,133 $998,000
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $4,442 - $6,197	30 Added 0.59%	5,128 $983,000
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $218,925 - $282,828	1,787 Added 53.97%	5,098 $752,000
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $312,326 - $465,129	3,311 New	3,311 $409,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Southeast Asset Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Southeast Asset Advisors Inc. with notifications on news.